Modified Manufacturing Process for Abicipar Shows Modest Improvement in IOI Incidence HCP Live, 22 May 2023 David Callahan, MD Credit: Texas Retina Associates A modified manufacturing process for 2mg abicipar pegol in the phase 2 MAPLE…